Literature DB >> 24406778

Accuracy and prognostic significance of electrocardiographic markers of left ventricular hypertrophy in a general population: findings from the Pressioni Arteriose Monitorate E Loro Associazioni population.

Cesare Cuspidi1, Rita Facchetti, Michele Bombelli, Carla Sala, Guido Grassi, Giuseppe Mancia.   

Abstract

AIM: We assessed the value of three electrocardiographic (ECG) voltage criteria in detecting left ventricular hypertrophy (LVH) and in predicting cardiovascular events and all-cause mortality in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) population.
METHODS: At entry, 1549 individuals (age 50 ± 13 years, 50.5% men) underwent diagnostic tests including laboratory investigations, 24-h ambulatory blood pressure monitoring, and standard ECG and echocardiography.
RESULTS: The sensitivity of ECG criteria for LVH was lowest for Sokolow-Lyon voltage (1.5 and 0.78%), intermediate for Cornell voltage (20.5 and 19.0%), and highest for RaVL wave amplitude (26.0 and 36.2%), independently of whether left ventricular mass was indexed to body surface area or height, respectively. After adjustment for age, sex, night-time SBP, low-density lipoprotein and high-density lipoprotein cholesterol, serum glucose, BMI, smoking, and previous cardiovascular events, only Cornell voltage index [hazard ratio for a 0.1  mV increase: 1.050, 95% confidence interval (CI): 1.017-1.083, P < 0.003] predicted an increased risk of cardiovascular events as well as all-cause mortality. Furthermore, when the categorical relationship between ECG-graphic LVH and cardiovascular outcomes was investigated in multiple models, only LVH identified by the Cornell voltage index remained an independent predictor of cardiovascular events (hazard ratio = 2.466, CI 1.459-4.168, P = 0.0008) and all-cause deaths (hazard ratio = 2.984, CI 1.380-6.449, P = 0.005).
CONCLUSION: Despite the limited sensitivity of ECG voltage criteria in detecting LVH, our results show that Cornell voltage index may improve cardiovascular risk stratification in a general population independently of several confounding factors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24406778     DOI: 10.1097/HJH.0000000000000085

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  13 in total

Review 1.  Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study.

Authors:  Cesare Cuspidi; Carla Sala; Anna Casati; Michele Bombelli; Guido Grassi; Giuseppe Mancia
Journal:  Hypertens Res       Date:  2016-11-17       Impact factor: 3.872

2.  Long-Term Effects of an Intensive Lifestyle Intervention on Electrocardiographic Criteria for Left Ventricular Hypertrophy: The Look AHEAD Trial.

Authors:  Tina E Brinkley; Andrea Anderson; Elsayed Z Soliman; Alain G Bertoni; Frank Greenway; William C Knowler; Stephen P Glasser; Edward S Horton; Mark A Espeland
Journal:  Am J Hypertens       Date:  2018-04-13       Impact factor: 2.689

3.  Does QRS Voltage Correction by Body Mass Index Improve the Accuracy of Electrocardiography in Detecting Left Ventricular Hypertrophy and Predicting Cardiovascular Events in a General Population?

Authors:  Cesare Cuspidi; Rita Facchetti; Michele Bombelli; Carla Sala; Marijana Tadic; Guido Grassi; Giuseppe Mancia
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-09-23       Impact factor: 3.738

4.  Comprehensive First-Line Magnetic Resonance Imaging in Hypertension: Experience From a Single-Center Tertiary Referral Clinic.

Authors:  Amy E Burchell; Jonathan C L Rodrigues; Max Charalambos; Laura E K Ratcliffe; Emma C Hart; Julian F R Paton; Andreas Baumbach; Nathan E Manghat; Angus K Nightingale
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-10-19       Impact factor: 3.738

5.  Do Combined Electrocardiographic and Echocardiographic Markers of Left Ventricular Hypertrophy Improve Cardiovascular Risk Estimation?

Authors:  Cesare Cuspidi; Rita Facchetti; Carla Sala; Michele Bombelli; Marijana Tadic; Guido Grassi; Giuseppe Mancia
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-05-10       Impact factor: 3.738

6.  Performance of Sokolow-Lyon index in detection of echocardiographically diagnosed left ventricular hypertrophy in a normal Eastern German population - results of the CARLA study.

Authors:  Jochen Schröder; Sebastian Nuding; Ursula Müller-Werdan; Karl Werdan; Alexander Kluttig; Martin Russ; Karin H Greiser; Jan A Kors; Johannes Haerting; Daniel Medenwald
Journal:  BMC Cardiovasc Disord       Date:  2015-07-14       Impact factor: 2.298

7.  Models for improved diagnosis of left ventricular hypertrophy based on conventional electrocardiographic criteria.

Authors:  Nan Lu; Jin-Xiu Zhu; Pei-Xuan Yang; Xue-Rui Tan
Journal:  BMC Cardiovasc Disord       Date:  2017-08-08       Impact factor: 2.298

8.  Carotid Atherosclerosis and Electrocardiographic Left Ventricular Hypertrophy in the General Population: The Namwon Study.

Authors:  Nam-Ho Kim; Min-Ho Shin; Sun-Seog Kweon; Jum Suk Ko; Young-Hoon Lee
Journal:  Chonnam Med J       Date:  2017-05-25

9.  Prognostic implications of left ventricular hypertrophy diagnosed on electrocardiogram vs echocardiography.

Authors:  Line Reinholdt Pedersen; Anna Meta Dyrvig Kristensen; Søren Sandager Petersen; Muthiah Vaduganathan; Deepak L Bhatt; Jacob Juel; Christina Byrne; Margrét Leósdóttir; Michael H Olsen; Manan Pareek
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-19       Impact factor: 3.738

10.  Effectiveness of Chlorthalidone Plus Amiloride for the Prevention of Hypertension: The PREVER-Prevention Randomized Clinical Trial.

Authors:  Sandra Costa Fuchs; Carlos E Poli-de-Figueiredo; José A Figueiredo Neto; Luiz César N Scala; Paul K Whelton; Francisca Mosele; Renato Bandeira de Mello; José F Vilela-Martin; Leila B Moreira; Hilton Chaves; Marco Mota Gomes; Marcos R de Sousa; Ricardo Pereira E Silva; Iran Castro; Evandro José Cesarino; Paulo Cesar Jardim; João Guilherme Alves; André Avelino Steffens; Andréa Araujo Brandão; Fernanda M Consolim-Colombo; Paulo Ricardo de Alencastro; Abrahão Afiune Neto; Antônio C Nóbrega; Roberto Silva Franco; Dario C Sobral Filho; Alexandro Bordignon; Fernando Nobre; Rosane Schlatter; Miguel Gus; Felipe C Fuchs; Otávio Berwanger; Flávio D Fuchs
Journal:  J Am Heart Assoc       Date:  2016-12-13       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.